Committed to sharing our science

Committed to sharing our science

409 results available

Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical Trial

JAMA Cardiology

Lewis, GD et al.

June 17, 2026
Serum Magnesium and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction: Insights From the GALACTIC-HF Trial

Oral Presentation, ESC 2025

Chimura, M et al.

August 31, 2025
Omecamtiv Mecarbil and Red Cell Distribution Width in Patients With Heart Failure and Reduced Ejection Fraction: Results From the GALACTIC-HF Trial

Oral Presentation, ESC 2025

Yang, M et al.

August 30, 2025
Real-world Burden of Hypertrophic Cardiomyopathy on Healthcare Use and Health-related Quality of Life in Italy, Spain, and the United States

Journal of Medical Economics

Gebrehiwet, P et al.

June 1, 2026
An Open-label Extension Study of Aficamten for Chinese Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: 48-week Results

Poster, ESC-HFA 2026

Zhang, Y et al.

May 10, 2026